EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evidence of a Sjögren’s disease–like phenotype following COVID-19 in mice and humans

Yiran Shen, Alexandria Voigt, Laura Goranova, Mehdi Abed, David E Kleiner, Jose O Maldonado, Margaret Beach, Eileen Pelayo, John A Chiorini, William F Craft, David A Ostrov, Vijay Ramiya und 6 weitere

JCI Insight · 22.12.2023 · 8 (24)

DOI: 10.1172/jci.insight.166540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 22.12.2023. Verfasst von Yiran Shen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: COVID-19, Sjogren's Syndrome. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, Intramural NIH HHS, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sjögren’s Disease (SjD) is a systemic autoimmune disease characterized by lymphocytic inflammation of the lacrimal and salivary glands (SG), dry eyes and mouth, and systemic symptoms. SARS-CoV-2 may trigger the development or progression of autoimmune diseases. To test this, we used a mouse model of SARS-CoV-2 infection and convalescent patients’ blood and SG in order to understand the development of SjD-like autoimmunity after infection. First, SARS-CoV-2–infected human angiotensin-converting enzyme 2 (ACE2) transgenic mice exhibited decreased salivation, elevated antinuclear antibodies (ANA), and lymphocytic infiltration in the lacrimal and SG. The sera from patients with COVID-19 sera showed increased ANA (i.e., anti-SSA [Sjögren’s-syndrome-related antigen A]/anti-Ro52 and anti-SSB [SS-antigen B]/anti-La). Male patients showed elevated anti-SSA compared with female patients, and female patients exhibited diverse ANA patterns. SG biopsies from convalescent COVID-19 patients were microscopically similar to SjD SG with focal lymphocytic infiltrates in 4 of 6 patients and 2 of 6 patients exhibiting focus scores of at least 2. Lastly, monoclonal antibodies produced in recovered patients blocked ACE2/spike interaction and cross-reacted with nuclear antigens. Our study shows a direct association between SARS-CoV-2 and SjD. Hallmark features of SjD-affected SGs were histologically indistinguishable from convalescent COVID-19 patients. The results implicate that SARS-CoV-2 could be an environmental trigger for SjD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Sjogren's SyndromeHumansMiceMaleFemaleAnimalsAngiotensin-Converting Enzyme 2SARS-CoV-2Mice, TransgenicPhenotype

Stichwörter der Autor:innen

AutoimmunityCOVID-19Rheumatology

Substanzen

Angiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
  • Salivary Disorder Unit, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland, USA.
  • Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • AAV Biology Section, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland, USA.
  • Center for Oral Health Integration, HealthPartners Institute, Bloomington, MN, USA.
  • Department of Comparative, Diagnostic, and Population Medicine, College of Veterinary Medicine, and.

Förderung

  • NIDCR NIH HHS
  • Intramural NIH HHS
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Shen, Y., Voigt, A., Goranova, L., Abed, M., Kleiner, D. E., Maldonado, J. O., Beach, M., Pelayo, E., Chiorini, J. A., Craft, W. F., Ostrov, D. A., Ramiya, V., Sukumaran, S., Brown, A. N., Hanrahan, K. C., Tuanyok, A., Warner, B. M., & Nguyen, C. Q. (2023). Evidence of a Sjögren’s disease–like phenotype following COVID-19 in mice and humans. JCI Insight, 8(24). https://doi.org/10.1172/jci.insight.166540

Vancouver

Shen Y, Voigt A, Goranova L, Abed M, Kleiner DE, Maldonado JO, et al. Evidence of a Sjögren’s disease–like phenotype following COVID-19 in mice and humans. JCI Insight. 2023;8(24). doi:10.1172/jci.insight.166540

BibTeX
@article{Shen2023,
  author = {Shen, Yiran and Voigt, Alexandria and Goranova, Laura and Abed, Mehdi and Kleiner, David E and Maldonado, Jose O and Beach, Margaret and Pelayo, Eileen and Chiorini, John A and Craft, William F and Ostrov, David A and Ramiya, Vijay and Sukumaran, Sukesh and Brown, Ashley N and Hanrahan, Kaley C and Tuanyok, Apichai and Warner, Blake M and Nguyen, Cuong Q},
  title = {Evidence of a Sjögren’s disease–like phenotype following COVID-19 in mice and humans},
  journal = {JCI Insight},
  year = {2023},
  volume = {8},
  number = {24},
  doi = {10.1172/jci.insight.166540}
}
Kostenlos starten →